Sonoma Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Sonoma Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 4% to $12,735,000. The net income raised on -$4,835,000 and profit margin reached -38%. Total operating expenses were $9,446,000.
Profit Margin
| 2015 | 13.85M | -8.20M | -59.21% |
|---|---|---|---|
| 2016 | 15.08M | -10.16M | -67.37% |
| 2017 | 12.82M | 9.27M | 72.31% |
| 2018 | 16.65M | -14.32M | -86.01% |
| 2019 | 18.97M | -11.79M | -62.19% |
| 2020 | 18.93M | -2.94M | -15.56% |
| 2021 | 18.62M | -4.61M | -24.77% |
| 2022 | 12.62M | -5.08M | -40.28% |
| 2023 | 13.27M | -5.15M | -38.81% |
| 2024 | 12.73M | -4.83M | -37.97% |
SNOA Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 12.73M | 13.27M | 12.62M | 18.62M | 18.93M | 18.97M | 16.65M | 12.82M | 15.08M | 13.85M |
Cost of revenue | 7.99M | 8.79M | 8.63M | 12.07M | 10.60M | 10.09M | 9.34M | 7.15M | 7.87M | 6.56M |
Gross profit | 4.74M | 4.47M | 3.99M | 6.55M | 8.33M | 8.88M | 7.31M | 5.66M | 7.21M | 7.28M |
Operating exp. | ||||||||||
Research and development | 1.87M | 207K | 125K | 555K | 1.33M | 1.51M | 1.57M | 1.57M | 1.80M | 1.53M |
Selling and marketing | 156K | 156K | 86K | 41K | 35K | 157K | 0 | 149K | 0 | 231K |
Total operating expenses | 9.44M | 9.04M | 9.88M | 10.00M | 15.00M | 20.13M | 21.49M | 18.64M | 17.36M | 13.94M |
Operating income | -4.70M | -4.57M | -5.88M | -3.44M | -6.67M | -11.25M | -14.18M | -12.97M | -10.15M | -6.65M |
Other income (expenses), net | -330K | -614K | 469K | -453K | 3.84M | -239K | -357K | 37K | -9K | -1.54M |
Income before tax | -5.03M | -5.18M | -5.41M | -3.90M | -2.82M | -11.34M | -14.32M | -12.93M | -10.16M | -8.20M |
Income tax expense | -196K | -33K | -332K | 713K | 121K | 458K | -807K | -4.26M | -241K | -250K |
Net income | -4.83M | -5.15M | -5.08M | -4.61M | -2.94M | -11.79M | -14.32M | 9.27M | -10.16M | -8.20M |
Earnings per share | ||||||||||
Basic EPS | -10.64 | -30.4 | -1.92 | -2.31 | -39.8 | -12.77 | -28.49 | 390.6 | -27.81 | -764.4 |
Diluted EPS | -10.64 | -30.4 | -1.92 | -2.31 | -39.8 | -12.77 | -28.47 | 390.6 | -27.81 | -764.4 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |